Advertisement

The ATS 3f Aortic Bioprosthesis

  • James L. Cox

Abstract

Artificial tissue valves are less durable than artificial mechanical valves but they require less anticoagulation than mechanical valves and, thus, are associated with fewer bleeding complications. The past 40 years have witnessed persistent efforts to manufacture either a mechanical valve that does not require warfarin therapy or a tissue valve with greater long-term durability. The ATS 3f Aortic Bioprosthesis was developed specifically to address the durability problem with previously designed artificial tissue valves.

Keywords

Aortic Valve Aortic Root Valve Leaflet Native Valve Bovine Pericardium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cox JL, Ad N, Myers K, Gharib M, Quijano RC (2005) Tubular heart valves: a new tissue prosthesis design — preclinical evaluation of the 3F aortic bioprosthesis. J Thorac Cardiovasc Surg 130(2):520–527CrossRefPubMedGoogle Scholar
  2. 2.
    Mueller XM, von Segesser LK (2003) A new equine pericardial stentless valve. J Thorac Cardiovasc Surg 125(6):1405–1411CrossRefPubMedGoogle Scholar
  3. 3.
    Sadowski J, Kapelak B, Bartu K, My J, Drwita R (2004) Stentless 3F Therapeutics Aortic Bioprosthesis — a new alternative to aortic valve replacement. Acta Cardiol 59(2):231–232PubMedGoogle Scholar
  4. 4.
    Doss M, Martens S, Wood JP, Miskovic A, Christodoulou T, Wimmer-Greinecker G, Moritz A (2005) Aortic leaflet replacement with the new 3F stentless aortic bioprosthesis. Ann Thorac Surg 79(2):682–685CrossRefPubMedGoogle Scholar
  5. 5.
    Eckstein FS, Tevaearai H, Keller D, Schmidli J, Immer FF, Seiler C, Saner H, Carrel TP (2004) Early clinical experience with a new tubular equine pericardial stentless aortic valve. Heart Surg Forum 7(5):E498–502CrossRefPubMedGoogle Scholar
  6. 6.
    Grubitzsch H, Linneweber J, Kossagk C, Sanli E, Beholz S, Konertz WF (2005) Aortic valve replacement with new-generation stentless pericardial valves: shortterm clinical and hemodynamic results. J Heart Valve Dis 14(5):623–629PubMedGoogle Scholar
  7. 7.
    Linneweber J, Kossagk C, Rogge ML, Dushe S, Dohmen P, Konertz W (2006) Clinical experience with the 3F stentless aortic bioprosthesis: one-year follow up. J Heart Valve Dis 15(4):545–548PubMedGoogle Scholar
  8. 8.
    Jin XY: Personal CommunicationGoogle Scholar
  9. 9.
    Jin XY, Du X, Kattach H, Ratnatunga C, Pillai R (2009) Effects of prosthetic valve substitute on aortic root geometry and dynamics. Submitted to Annals of Thoracic SurgeryGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • James L. Cox
    • 1
  1. 1.ATS Medical, Inc.MinneapolisUSA

Personalised recommendations